Advanced Magnetics, Inc. develops superparamagnetic iron oxide nanoparticles used in pharmaceutical products primarily the United States, Europe, and Japan. It focuses on the development and commercialization of its proprietary nanoparticle technology for use in therapeutic iron compounds to treat anemia, as well as imaging agents to aid in the diagnosis of cancer and cardiovascular disease. The company markets two products, Feridex I.V. and GastroMARK primarily in Europe and the United States. Feridex I.V. is a liver contrast agent; and GastroMARK is an oral contrast agent used for delineating the bowel in MRI. Its primary product candidate, Ferumoxytol, is in Phase III multi-center...